Maintenance tamoxifen after induction postoperative chemotherapy in node-positive breast cancer patients: the Eastern Cooperative Oncology Group Trials

Recent Results Cancer Res. 1993:127:185-96. doi: 10.1007/978-3-642-84745-5_26.
No abstract available

Publication types

  • Clinical Trial
  • Randomized Controlled Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Antineoplastic Combined Chemotherapy Protocols / adverse effects
  • Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
  • Breast Neoplasms / drug therapy*
  • Breast Neoplasms / mortality
  • Breast Neoplasms / surgery
  • Chemotherapy, Adjuvant
  • Cyclophosphamide / administration & dosage
  • Doxorubicin / administration & dosage
  • Drug Administration Schedule
  • Female
  • Fluorouracil / administration & dosage
  • Fluoxymesterone / administration & dosage
  • Humans
  • Lymphatic Metastasis
  • Mastectomy
  • Methotrexate / administration & dosage
  • Neoplasm Recurrence, Local
  • Prednisone / administration & dosage
  • Receptors, Estrogen / analysis
  • Survival Rate
  • Tamoxifen / administration & dosage
  • Tamoxifen / therapeutic use*
  • Thiotepa / administration & dosage
  • Vinblastine / administration & dosage

Substances

  • Receptors, Estrogen
  • Tamoxifen
  • Vinblastine
  • Doxorubicin
  • Cyclophosphamide
  • Thiotepa
  • Fluoxymesterone
  • Fluorouracil
  • Prednisone
  • Methotrexate

Supplementary concepts

  • CMFPT protocol
  • TAVH protocol